Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuronytics is a precision brain health company that leverages advanced electroencephalography (EEG) and artificial intelligence to provide objective insights into neurological and psychiatric health. The company's proprietary platform captures and analyzes brain activity to identify digital biomarkers that assist in the diagnosis, treatment planning, and monitoring of conditions such as depression and cognitive decline. By integrating high-fidelity sensors with machine learning algorithms, Neuronytics aims to transition mental healthcare from subjective assessments to data-driven clinical decisions. Their technology is designed for use in both clinical research and routine medical practice to standardize brain health assessment. The platform provides actionable data to help clinicians personalize therapy and improve patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuronytics.